CURR: CURRENC Group Inc. Stock

by  •  • Comments Off on CURR: CURRENC Group Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 23.26
Enterprise Value ($M) 20.86
Book Value ($M) -43.93
Book Value / Share -1.47
Price / Book -0.53
NCAV ($M) -60.75
NCAV / Share -1.31
Price / NCAV -0.38

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.32
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.61
Current Ratio 0.61

Balance Sheet (mrq) ($M)
Current Assets 93.94
Assets 110.76
Liabilities 154.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 46.44
Operating Income -27.38
Net Income -39.48
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 3.45
Cash from Investing -0.57
Cash from Financing 2.02

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Polar Asset Management Partners Inc. 0.00 -100.00
11-14 13G/A Glazer Capital, Llc 0.00 -100.00
11-13 13G/A Cowen And Company, Llc 0.00 -100.00
09-10 13G/A Vivaldi Asset Management, LLC 0.00 -100.00
09-05 13G/A Wolverine Asset Management Llc 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-10-09 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2024-10-09 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2024-10-09 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-04 103,354 798,668 12.94
2025-06-03 103,074 1,014,292 10.16
2025-06-02 52,996 642,451 8.25
2025-05-30 191,118 1,181,404 16.18
2025-05-29 399,596 2,193,126 18.22

(click for more detail)

Similar Companies
CRON – Cronos Group Inc. CRSP – CRISPR Therapeutics AG
CRVS – Corvus Pharmaceuticals, Inc. CVAC – CureVac N.V.
EOLS – Evolus, Inc.


Financial data and stock pages provided by
Fintel.io